[{"address1": "1040 West Georgia Street", "address2": "Suite 1030", "city": "Vancouver", "state": "BC", "zip": "V6E 4H1", "country": "Canada", "phone": "604-210-2217", "website": "https://www.achievelifesciences.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Achieve Life Sciences, Inc., a clinical-stage pharmaceutical company, develops and commercializes cytisinicline for smoking cessation and nicotine addiction. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol Achieve Life Sciences, Inc. is based in Vancouver, Canada.", "fullTimeEmployees": 22, "companyOfficers": [{"maxAge": 1, "name": "Mr. Thomas B. King M.B.A.", "age": 69, "title": "Executive Chairman", "yearBorn": 1955, "fiscalYear": 2023, "totalPay": 51531, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Richard A. B. Stewart", "age": 65, "title": "CEO & Executive Director", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 663750, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Cindy  Jacobs M.D., Ph.D.", "age": 66, "title": "President, Chief Medical Officer & Director", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 652740, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark K. Oki CPA", "age": 55, "title": "Chief Financial Officer", "yearBorn": 1969, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jerry  Wan", "age": 42, "title": "Principal Accounting Officer", "yearBorn": 1982, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony  Clarke Ph.D.", "age": 68, "title": "Chief Scientific Officer", "yearBorn": 1956, "fiscalYear": 2023, "totalPay": 546000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jaime  Xinos", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Mark L. Rubinstein", "title": "Head of Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Craig  Donnelly", "title": "Executive Vice President of CMC & Regulatory CMC", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 9, "boardRisk": 10, "compensationRisk": 8, "shareHolderRightsRisk": 4, "overallRisk": 8, "governanceEpochDate": 1735689600, "compensationAsOfEpochDate": 1703980800, "irWebsite": "http://ir.oncogenex.com/index.cfm", "maxAge": 86400, "priceHint": 4, "previousClose": 3.07, "open": 3.09, "dayLow": 3.02, "dayHigh": 3.14, "regularMarketPreviousClose": 3.07, "regularMarketOpen": 3.09, "regularMarketDayLow": 3.02, "regularMarketDayHigh": 3.14, "beta": 1.583, "forwardPE": -2.653978, "volume": 359650, "regularMarketVolume": 359650, "averageVolume": 164356, "averageVolume10days": 348980, "averageDailyVolume10Day": 348980, "bid": 2.24, "ask": 3.89, "bidSize": 100, "askSize": 200, "marketCap": 106264792, "fiftyTwoWeekLow": 3.02, "fiftyTwoWeekHigh": 5.59, "fiftyDayAverage": 4.1236, "twoHundredDayAverage": 4.57835, "currency": "USD", "enterpriseValue": 73198936, "floatShares": 32581723, "sharesOutstanding": 34389900, "sharesShort": 3811534, "sharesShortPriorMonth": 2858594, "sharesShortPreviousMonthDate": 1732838400, "dateShortInterest": 1735603200, "sharesPercentSharesOut": 0.1108, "heldPercentInsiders": 0.09724, "heldPercentInstitutions": 0.59598, "shortRatio": 24.87, "shortPercentOfFloat": 0.1447, "impliedSharesOutstanding": 36742400, "bookValue": 0.912, "priceToBook": 3.3881578, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -32943000, "trailingEps": -1.12, "forwardEps": -1.15, "lastSplitFactor": "1:20", "lastSplitDate": 1596153600, "enterpriseToEbitda": -2.358, "52WeekChange": -0.3252747, "SandP52WeekChange": 0.22408533, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "ACHV", "underlyingSymbol": "ACHV", "shortName": "Achieve Life Sciences, Inc.", "longName": "Achieve Life Sciences, Inc.", "firstTradeDateEpochUtc": 813504600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "a8d5007a-e79a-3fda-b122-9798e9ba8d73", "messageBoardId": "finmb_415241078", "gmtOffSetMilliseconds": -18000000, "currentPrice": 3.09, "targetHighPrice": 30.0, "targetLowPrice": 10.0, "targetMeanPrice": 16.44444, "targetMedianPrice": 14.0, "recommendationMean": 1.125, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 9, "totalCash": 42911000, "totalCashPerShare": 1.248, "ebitda": -31037000, "totalDebt": 9845000, "quickRatio": 6.389, "currentRatio": 6.779, "debtToEquity": 31.375, "returnOnAssets": -0.54089, "returnOnEquity": -1.86035, "freeCashflow": -14935875, "operatingCashflow": -24945000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2025-01-18"}]